Johns Hopkins Medicine has provided international leadership in the education of physicians and medical scientists, in biomedical research, and in the application of medical knowledge to sustain health since the opening of The Johns Hopkins Hospital in 1889. Today, Hopkins Medicine brings together the faculty physicians and scientists of The Johns Hopkins University School of Medicine with the organizations, community physicians, nurses and other professionals of The Johns Hopkins Health System to continue that mission.

Our mission is to determine the function and role of micronutrients (vitamins and minerals) and phytochemicals (chemicals from plants) in promoting optimum health and preventing and treating disease; to determine the role of oxidative and nitrative stress and antioxidants in human health and disease; and to help people everywhere achieve a healthy and productive life, full of vitality, with minimal suffering, and free of cancer and other debilitating diseases. Major areas of research in the Institute encompass heart disease, cancer, aging, and neurodegenerative diseases. Specific laboratories address antioxidants and vascular biology; vitamin E metabolism and biological activity; colon cancer and cancer chemoprevention by phytochemicals; the role of nitric oxide and oxidative stress in neurodegenerative diseases, such as ALS (Lou Gehrig's disease); and the role of oxidative stress and mitochondrial dysfunction in the aging process.

Prof. Mao's research interest is in the design, synthesis and application of polymeric materials for drug and gene delivery and tissue engineering.

The Marine and Freshwater Biomedical Sciences Center has as its mission the development and use of aquatic models to investigate environmental problems of human health concern. As recognized by the National Institutes of Health, aquatic models can be used as sensitive, low-cost, comparative vertebrate models that reduce dependence on mammalian species for health-related research.

The Marine Biological Laboratory is an international center for research, education, and training in biology, biomedicine, and ecology. Learn about our facilities, our community, and why Lewis Thomas called us America's "National Biological Laboratory."

The North Pacific Universities Marine Mammal Research Consortium conducts research on the relationship between fisheries and marine mammals in the North Pacific Ocean and the Eastern Bering Sea.

The McDonald Institute for Archaeological Research in the University of Cambridge was established in 1990 through a generous benefaction from the late Dr D M McDonald,
a well-known and successful industrialist. The Institute provides support for Cambridge-based researchers in many branches of archaeology, but has a particular interest in the archaeology of early human cognition. The Institute also places emphasis on archaeological science, and contains laboratories for geoarchaeology, archaeozoology, archaeobotany and artefact analysis. The extensive faunal remains collection of the Department of Archaeology is now based within the McDonald Institute and a corresponding reference collection of plant remains is being assembled.

The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. Enormous progress toward finding a cure has been made on many neurological fronts, and scientists' understanding of the brain and how disease affects it has increased dramatically. The Foundation seeks to hasten progress further by awarding grants that help guarantee that new and innovative research avenues are thoroughly funded and explored. Actor Michael J. Fox established the Foundation in May 2000 shortly after announcing his retirement from the ABC television show Spin City. In 1998 he publicly disclosed that he had been diagnosed with young-onset Parkinson's disease seven years earlier.

A microbiology information portal containing a vast collection of resources including articles, news, frequently asked questions, and links pertaining to the field of microbiology.

The MIT Center for Cancer Research (CCR) was founded in 1974, and is one of eight National Cancer Institute-designated basic research centers. Our mission is to apply the tools of basic science and technology to determine how cancer is caused, progresses and responds to treatment. Through this effort we have developed an increasingly complete understanding of the nature of cancer cells, which as led directly to improved treatments for the disease. Molecules identified by CCR research teams were used as targets for two of the first few FDA-approved cancer-fighting drugs produced by molecular medicine (approved by the FDA in 1998 and 2001). Today, the Center for Cancer Research continues to generate critical new insights into the basic mechanisms of cancer that are essential for advancing diagnosis and treatment of cancer. We remain committed to our founding vision that we can conquer cancer through research and technology.

The mission of the National Biomedical Computation Resource is to conduct, catalyze, and enable biomedical research by harnessing, developing, and deploying forefront computational, information and grid technologies.

The National Cancer Institute (NCI) is a component of the National Institutes of Health (NIH), one of eight agencies that compose the Public Health Service (PHS) in the Department of Health and Human Services (DHHS). The NCI, established under the National Cancer Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice. The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Scientists at NCEAS use existing information to address important questions in ecology, ecoinformatics and allied disciplines. At NCEAS, scientists conduct collaborative research on major fundamental and applied problems in ecology. The Center has a critical responsibility to apply general knowledge of ecological systems to specific issues such as the massive and accelerating loss of biotic diversity, global change, habitat decline and fragmentation, over-exploitation of natural resources, and pollution of air, water, and soil. Hundreds of scholars, including Postdoctoral Associates, Center Fellows, and visitors in Working Groups collaborate each year at the Center on scores of projects. NCEAS, a research center of the University of California, Santa Barbara, is located in downtown Santa Barbara.

The National Center for Research Resources (NCRR) is a component of the National Institutes of Health. NCRR supports primary research to create and develop critical resources, models, and technologies. NCRR funding also provides biomedical researchers with access to diverse instrumentation, technologies, basic and clinical research facilities, animal models, genetic stocks, biomaterials, and more. These resources enable scientific advances in biomedicine that lead to the development of lifesaving drugs, devices, and therapies.

The National Human Genome Research Institute (NHGRI) led the National Institutes of Health's (NIH) contribution to the International Human Genome Project, which had as its primary goal the sequencing of the human genome. This project was successfully completed in April 2003. Now, the NHGRI's mission has expanded to encompass a broad range of studies aimed at understanding the structure and function of the human genome and its role in health and disease. To that end NHGRI supports the development of resources and technology that will accelerate genome research and its application to human health. A critical part of the NHGRI mission continues to be the study of the ethical, legal and social implications (ELSI) of genome research. NHGRI also supports the training of investigators and the dissemination of genome information to the public and to health professionals.